Advertisement
Screener

Twist Bioscience Corporation (TWST) Expense Breakdown

Twist Bioscience Corporation Expense Breakdown

No Expense Breakdown for TWST on this site yet.

  • 2026-06-30: Reportable $49.79M.
  • 2025-06-30: Reportable $38.52M.

Source checked: the stored Expense Breakdown page for TWST.

Expenses by product

Cost Of Revenue Excluding Depreciation Amortization And Share Based Compensation Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$49.79M
2025-06-30$38.52M

Costs and Expenses: each quarter (3 month)

Quarter endReportable
2026-06-30$154.66M
2025-06-30$126.18M

Depreciation, Depletion and Amortization: each quarter (3 month)

Quarter endReportable
2026-06-30$6.78M
2025-06-30$6.07M

Income Tax Expense (Benefit): each quarter (3 month)

Quarter endReportable
2026-06-30$311.00K
2025-06-30$191.00K

Research And Development Expense Excluding Depreciation Amortization And Share Based Compensation Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$15.99M
2025-06-30$16.89M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78